SD Biosensor Inc Asset Resilience Ratio
SD Biosensor Inc asset resilience ratio. SD Biosensor Inc (137310) has an Asset Resilience Ratio of 7.56% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of SD Biosensor Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of SD Biosensor Inc (2019–2025)
Asset resilience ratio of SD Biosensor Inc from 2019 to 2025. This chart shows how SD Biosensor Inc's Asset Resilience Ratio has changed over time. Read SD Biosensor Inc (137310) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down SD Biosensor Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SD Biosensor Inc asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩219.29 Billion | 7.56% |
| Total Liquid Assets | ₩219.29 Billion | 7.56% |
Asset Resilience Insights
- Limited Liquidity: SD Biosensor Inc maintains only 7.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SD Biosensor Inc Industry Peers by Asset Resilience Ratio
Compare SD Biosensor Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
SD Biosensor Inc Asset Resilience Ratio by Year (2019–2025)
SD Biosensor Inc asset resilience ratio by year from 2019 to 2025. The table below shows the annual Asset Resilience Ratio data for SD Biosensor Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 12.56% | ₩407.39 Billion ≈ $276.09 Million |
₩3.24 Trillion ≈ $2.20 Billion |
+5.10pp |
| 2024-12-31 | 7.47% | ₩290.33 Billion ≈ $196.75 Million |
₩3.89 Trillion ≈ $2.64 Billion |
+5.48pp |
| 2023-12-31 | 1.99% | ₩75.33 Billion ≈ $51.05 Million |
₩3.79 Trillion ≈ $2.57 Billion |
-4.05pp |
| 2022-12-31 | 6.04% | ₩197.03 Billion ≈ $133.52 Million |
₩3.26 Trillion ≈ $2.21 Billion |
-27.70pp |
| 2021-12-31 | 33.74% | ₩1.01 Trillion ≈ $687.11 Million |
₩3.01 Trillion ≈ $2.04 Billion |
+18.61pp |
| 2020-12-31 | 15.13% | ₩221.15 Billion ≈ $149.87 Million |
₩1.46 Trillion ≈ $990.54 Million |
+3.30pp |
| 2019-12-31 | 11.83% | ₩20.08 Billion ≈ $13.60 Million |
₩169.72 Billion ≈ $115.02 Million |
-- |
About SD Biosensor Inc
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volum… Read more